• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,741.82 238.22
( 0.31%)
Global Indices
Nasdaq
52,357.11 -589.04
(-1.11%)
Dow Jones
7,503.65 -21.20
(-0.28%)
Hang Seng
67,966.49 1,147.44
(1.72%)
Nikkei 225
10,469.05 -196.83
(-1.85%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
22.92
15943.23
EPS(TTM)
Face Value()
Div & Yield %
35.39
2
1.48
 

pakka ltd
Goodricke Group reports standalone net loss of Rs 29.21 crore in the March 2026 quarter
May 28,2026
Net Loss of Goodricke Group reported to Rs 29.21 crore in the quarter ended March 2026 as against net loss of Rs 36.57 crore during the previous quarter ended March 2025. Sales declined 21.23% to Rs 103.85 crore in the quarter ended March 2026 as against Rs 131.84 crore during the previous quarter ended March 2025.

For the full year,net profit rose 27.37% to Rs 25.55 crore in the year ended March 2026 as against Rs 20.06 crore during the previous year ended March 2025. Sales declined 13.79% to Rs 801.29 crore in the year ended March 2026 as against Rs 929.44 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales103.85131.84 -21 801.29929.44 -14
OPM %-23.65-37.92 -2.412.07 -
PBDT-24.30-40.95 41 28.5028.57 0
PBT-28.73-45.55 37 10.328.73 18
NP-29.21-36.57 20 25.5520.06 27